These compounds may interact with:
Tyrosine-protein phosphatase non-receptor type 11
Potentially involved in: leopard syndrome; noonan syndrome; immune system cancer; celiac disease; lymphoid leukemia; breast cancer; kidney cancer; carcinoma; hemolytic anemia; cardiofaciocutaneous syndrome; cancer; pulmonary valve stenosis; costello syndrome; hypertrophic cardiomyopathy; congenital heart disease; neurofibromatosis; cryptorchidism; gastritis; exostosis; ollier disease
Disease data sourced from Pharos.